LEADER 01278nem0-2200385---450- 001 990009384170403321 005 20111202135128.0 035 $a000938417 035 $aFED01000938417 035 $a(Aleph)000938417FED01 035 $a000938417 100 $a20110623d1952----km-y0itay50------ba 101 0 $aita 102 $aIT 120 $aa--------bl-- 121 $aaa-aabb-a$b-------- 123 1 $aa$b1:25000$do0003500$eo0003000$fn0461000$gn0460500 124 $a-$bd$c--$db$e-$f--$g-- 200 1 $aS. Giustina$bDocumento cartografico$fIstituto geografico militare 206 $a1:25000 ; proiezione conforme universale trasversa di Mercatore (O0°35'-O0°30'/N46°10'-N46°05') 210 $aFirenze$cIGM$d1952 215 $a1 carta$d39 x 37 su foglio 58 x 53 cm 225 1 $aCarta d'Italia$v23, quadrante 3, tavoletta NO 300 $aIl meridiano di riferimento è M. Mario, Roma 532 12$aSanta Giustina 540 1 $aFoglio 23, quadrante 3 tavoletta N. O. 610 0 $aVeneto$aCarte 710 02$aIstituto geografico militare$05005 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aMP 912 $a990009384170403321 952 $aMP Cass.2 023, 3(4)$bI.G. s.i.$fILFGE 959 $aILFGE 996 $aS. Giustina$9762841 997 $aUNINA LEADER 01611oam 2200433 a 450 001 9910702187003321 005 20120912150042.0 035 $a(CKB)5470000002424265 035 $a(OCoLC)400009435 035 $a(EXLCZ)995470000002424265 100 $a20090615d2005 ua 0 101 0 $aeng 135 $aurbn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aGuidance for industry$b[electronic resource] $eQ5E comparability of biotechnological/biological products subject to changes in their manufacturing process 210 1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2005] 215 $a1 online resource (14 pages) 300 $aTitle from title screen (viewed on June 16, 2009). 300 $a"ICH". 300 $a"June 2005". 320 $aIncludes bibliographical references (page 14). 517 $aGuidance for industry 606 $aBiotechnological process monitoring 606 $aPharmaceutical biotechnology 606 $aBiological products 615 0$aBiotechnological process monitoring. 615 0$aPharmaceutical biotechnology. 615 0$aBiological products. 712 02$aCenter for Drug Evaluation and Research (U.S.) 712 02$aCenter for Biologics Evaluation and Research (U.S.) 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910702187003321 996 $aGuidance for industry$93434577 997 $aUNINA